Clinical Experiences of Incidental Prostate Cancer after Transurethral Resection of Prostate (TURP) According to Initial Treatment: A Study of a Korean High Volume Center.
- Author:
Dong Hoon LEE
1
;
Doo Yong CHUNG
;
Kwang Suk LEE
;
In Kyong KIM
;
Koon Ho RHA
;
Young Deuk CHOI
;
Byung Ha CHUNG
;
Sung Joon HONG
;
Jang Hwan KIM
Author Information
- Publication Type:Original Article
- Keywords: Incidental prostate cancer; radical prostatectomy; active surveillance
- MeSH: Aged; Humans; Korea; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms/*surgery; Retrospective Studies; Transurethral Resection of Prostate/*methods
- From:Yonsei Medical Journal 2014;55(1):78-83
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: These are the clinical experiences of Korean incidental prostate cancer patients detected by transurethral resection of the prostate according to initial treatment: active surveillance (AS), radical prostatectomy (RP) and hormone therapy (HT). MATERIALS AND METHODS: We retrospectively reviewed the records of 156 incidental prostate cancer patients between 2001 and 2012. The clinicopathologic outcomes were reviewed and follow-up results were obtained. RESULTS: Among 156 patients, 97 (62.2%) had T1a and 59 (37.8%) had T1b. Forty-six (29.5%) received AS, 67 (42.9%) underwent RP, 34 (21.8%) received HT, 4 (2.6%) received radiotherapy, and 5 (3.2%) chose watchful waiting. Of 46 patients on AS, prostate-specific antigen (PSA) progression occurred in 12 (26.1%) patients. Among them, 3 patients refused treatment despite PSA progression. Five patients, who underwent RP as an intervention, all had organ-confined Gleason score < or =6 disease. In 67 patients who underwent RP, 50 (74.6%) patients had insignificant prostate cancer and 8 (11.9%) patients showed unfavorable features. During follow-up, biochemical recurrence occurred in 2 patients. Among 34 patients who received HT, 3 (8.8%) patients had PSA progression. Among 156 patients, 6 patients died due to other causes during follow-up. There were no patients who died due to prostate cancer. CONCLUSION: The clinical outcomes of incidental prostate cancer were satisfactory regardless of the initial treatment. However, according to recent researches and guidelines, immediate definite therapy should be avoided without a careful assessment. We also believe that improved clinical staging is needed for these patients.
